Sutro Biopharma posts Q2 loss, reports early STRO-004 trial data
Tweet Send to a Friend
Sutro Biopharma, Inc. (NASDAQ: STRO) reported a net loss of $38.5 million, or $2.33 per share, for the second quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
